aspartic acid has been researched along with Carcinoma, Non-Small Cell Lung in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| DI, LQ; Huang, X; Lu, YY; Luo, ZC; Qi, MY; Shan, JJ; Zhang, W | 1 |
| Hanada, K; Itatani, Y; Kawada, K; Maekawa, H; Miyoshi, H; Nishikawa, G; Obama, K; Taketo, MM | 1 |
| Choudhuri, R; Cook, JA; Gamson, J; Gohain, S; Leiker, AJ; Mathias, A; Mitchell, JB; Naz, S; Preston, O; Sowers, AL; Van Waes, C | 1 |
| Bouras, N; Bousahba, A; de Fraipont, F; Kebir, FZE; Megaïz, A; Sahraoui, T | 1 |
| Ahn, JM; Chen, PH; DeBerardinis, RJ; Dospoy, P; Frink, RE; Huffman, KE; Kim, DH; Kim, HS; Kim, J; Larsen, JE; Lewis, C; Lou, TF; Ma, X; Minna, JD; Sethuraman, D; Srivastva, P; Um, SW; White, MA; Yoo, H | 1 |
| Hong, KM; Jang, H; Kang, JH; Kim, SY; Lee, C; Lee, JS; Lee, SH; Nam, B; Seong, TW; Son, J | 1 |
| Hong, D; Hong, KM; Kang, JH; Kim, SY; Lee, JS; Lee, SH; Son, J; Song, J | 1 |
| Abdelmelek, MF; Blumenschein, GR; Byers, LA; Chen, L; Coombes, KR; Diao, L; Herbst, RS; Heymach, JV; Hong, WK; Ihle, NT; Kim, ES; Larsen, JE; Lee, JJ; Lippman, SM; Liu, S; Minna, JD; Papadimitrakopoulou, V; Powis, G; Saintigny, P; Tang, X; Tsao, A; Wang, J; Wistuba, II; Zhang, S | 1 |
| Cleaveland, ES; Cooney, DA; Ford, H; Kelley, JA; Paull, K; Zaharevitz, DW | 1 |
| Arioka, H; Fukumoto, H; Fukuoka, K; Ishida, T; Iwamoto, Y; Kurokawa, H; Narita, N; Nishio, K; Saijo, N; Suzuki, T; Tomonari, A; Usuda, J | 1 |
10 other study(ies) available for aspartic acid and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
[Mechanism of Cordyceps militaris against non-small cell lung cancer: based on serum metabolomics].
Topics: Alanine; Animals; Arginine; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cordyceps; Glutamic Acid; Glutamine; Glyoxylates; Humans; Lung Neoplasms; Metabolomics; Mice; Mice, Nude; Nitrogen; Phenylalanine; RNA, Transfer; Tryptophan; Tyrosine | 2022 |
Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.
Topics: Animals; Asparaginase; Asparagine; Aspartate-Ammonia Ligase; Aspartic Acid; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Glutamine; Humans; Lung Neoplasms; Mice; Mice, Nude; Proto-Oncogene Proteins p21(ras); RNA, Small Interfering; Spheroids, Cellular; Xenograft Model Antitumor Assays | 2022 |
Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis.
Topics: Animals; Aspartic Acid; Benzamides; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; DNA Damage; DNA Repair; Down-Regulation; G2 Phase Cell Cycle Checkpoints; Head and Neck Neoplasms; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Lung Neoplasms; M Phase Cell Cycle Checkpoints; Metabolomics; Mice; Mice, Nude; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Nucleotides; Radiation Tolerance; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2021 |
[In silico study of a functional mutation associated with non-small cell lung cancer: G12D mutation of exon 2 in KRAS gene].
Topics: Algeria; Amino Acid Substitution; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Computational Biology; Databases, Genetic; DNA Mutational Analysis; Exons; Genetic Association Studies; Glycine; Humans; Lung Neoplasms; Models, Molecular; Mutation, Missense; Proto-Oncogene Mas; Proto-Oncogene Proteins p21(ras); Software | 2019 |
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Topics: Acetyltransferases; Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Blood-Brain Barrier; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; Male; Middle Aged; RNA, Small Interfering; Sequence Analysis, RNA | 2016 |
Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.
Topics: Action Potentials; Adenosine Triphosphate; Aldehyde Dehydrogenase; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytosol; Female; Gossypol; Humans; Lung Neoplasms; Malates; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; NAD; NADP; Neoplasm Transplantation; Oxidative Phosphorylation; Oxidoreductases Acting on CH-NH Group Donors; Phenformin; RNA, Small Interfering | 2016 |
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
Topics: A549 Cells; Adenosine Triphosphate; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Death; Cell Proliferation; Cell Survival; Cytosol; Drug Synergism; Fluorouracil; Gene Knockdown Techniques; Glutamic Acid; Glutaminase; Glutamine; Lung Neoplasms; Malates; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; NAD; Oxidation-Reduction; Sulfides; Thiadiazoles; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2016 |
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome.
Topics: Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Clinical Trials, Phase II as Topic; Cysteine; Disease-Free Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, ras; Genetic Vectors; Glycine; Humans; Immunoblotting; Immunoprecipitation; Kaplan-Meier Estimate; Lentivirus; Lung Neoplasms; Microarray Analysis; Molecular Targeted Therapy; Mutation; Proto-Oncogene Proteins c-akt; Randomized Controlled Trials as Topic; Signal Transduction; TOR Serine-Threonine Kinases; Treatment Outcome; Valine | 2012 |
Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.
Topics: Antineoplastic Agents; Aspartic Acid; Biphenyl Compounds; Breast Neoplasms; Carbolines; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Colonic Neoplasms; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Female; Humans; Kidney Neoplasms; Kinetics; Leukemia; Lung Neoplasms; Male; Melanoma; Mitochondria; Orotic Acid; Ovarian Neoplasms; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Prostatic Neoplasms; Ribonucleotides; Sodium Bicarbonate; Software; Tumor Cells, Cultured | 1996 |
Ectopic p16(ink4) expression enhances CPT-11-induced apoptosis through increased delay in S-phase progression in human non-small-cell-lung-cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Aspartic Acid; Camptothecin; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase Inhibitors; Caspases; Cyclin A; Cyclin-Dependent Kinase Inhibitor p16; DNA Fragmentation; DNA, Complementary; Enzyme Activation; Gene Expression; Humans; Irinotecan; Lung Neoplasms; Protease Inhibitors; S Phase; Time Factors; Transfection; Tumor Cells, Cultured | 2000 |